Valens GroWorks Corp (CSE:VGW, OTC:MYMSF)  released its tenth episode on its Extraction podcast this week, which was sponsored by Leafly, one of the world’s largest cannabis information resources. Joining the hosts was Leafly Canada’s Managing Director Jo Vos, who is a senior brand marketing and strategy leader with expertise in building some of North America’s most iconic companies. During the podcast, Vos talked about working in cannabis, bringing the Leafly legacy to Canada and why cannabis is all about connection. Plus she provided insight into Leafly’s origins and what they have in store for 2019.

Vos described the Leafly brand in Canada as a “start-up within a start-up,” as they have to build the brand from scratch while adapting to the strict rules and regulations set forth by Health Canada. However, Vos pointed out that the Canadian market doesn’t have much to offer consumers when compared to the more mature and less conservative markets in the US.

“We want to be part of your success, whether you’re a retailer, or a brand, or a licensed producer, or a First Nations community,” said Vos.

Vos also announced that Leafly would be launching a new POS integration for retailers, which will allow them to display real-time inventory so consumers can see what’s in stock. Additionally, Vos believes that the future of cannabis will become more personalized as consumers educate themselves about cannabis and look towards wellness products to combat common issues like anxiety and sleep.

“Everybody is different. Your endocannabinoid system is a unique fingerprint…That’s why the curation piece is going to be so critical as people try to find consistency in these experiences,” said Vos.

To listen to the podcast, click here.

Click here to connect with Valens GroWorks Corp (CSE:VGW, OTC:MYMSF) for an Investor Presentation.

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less